Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus

This study has been completed.

Study NCT00496821 Information provided by Alnylam Pharmaceuticals

First Received: July 3, 2007 Last Updated: November 29, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2007
Estimated Primary Completion Date:	No date given